Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CERO | Common Stock | Sale | -$108K | -1.34M | -7.09% | $0.08 | 17.6M | Dec 11, 2024 | By YK Bioventures Opportunities Fund I, L.P. | F1 |
transaction | CERO | Common Stock | Sale | -$113K | -1.61M | -9.16% | $0.07 | 16M | Dec 12, 2024 | By YK Bioventures Opportunities Fund I, L.P. | F1 |
transaction | CERO | Common Stock | Sale | -$180K | -3M | -18.74% | $0.06 | 13M | Dec 13, 2024 | By YK Bioventures Opportunities Fund I, L.P. | F1 |
YK Bioventures Opportunities GP I, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Id | Content |
---|---|
F1 | Securities are held directly by YK Bioventures Opportunities Fund I, L.P. (f/k/a YK Bioventures, LLC) ("YK Opps I"). YK Bioventures Opportunities GP I, LLC ("YK Opps I GP") is the general partner of YK Opps I and may be deemed to beneficially own the shares held by YK Opps I. Mitchell W. Kossar and Gary K. Yeung are managing partners of YK Opps I GP, and may be deemed to share voting and investment power over the shares held by YK Opps I. Each of YK Opps I GP and Messrs. Kossar and Yeung disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein. |